Figure 3.
Investigational small-molecule inhibitors in phase II clinical trials in the last five years. The chemical structure is from “chemspider.com”.
Investigational small-molecule inhibitors in phase II clinical trials in the last five years. The chemical structure is from “chemspider.com”.